• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富血小板血浆(PRP)治疗卵巢可显著改善卵巢储备功能降低患者的生育参数和生殖结局:系统评价和荟萃分析。

Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis.

机构信息

Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.

Division of Pancreatic Diseases, Semmelweis University, Budapest, Hungary.

出版信息

J Ovarian Res. 2024 May 17;17(1):104. doi: 10.1186/s13048-024-01423-2.

DOI:10.1186/s13048-024-01423-2
PMID:38760869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11100055/
Abstract

INTRODUCTION

The incidence of infertility caused by diminished ovarian reserve has become a significant problem worldwide. The beneficial effect of PRP treatment of the ovaries has already been described, but the high-level evidence of its effectiveness has not yet been proven.

MATERIALS AND METHODS

A systematic search was performed in five databases, until March 12th, 2024. Both randomized and non-randomized studies that compared PRP treatment of the ovaries to self-control among women with diminished ovarian reserve were eligible for inclusion. Hormonal levels (Anti-Müllerian hormone (AMH), Follicle stimulating hormone (FSH), Luteinizing hormone (LH), Estradiol (E2), In-vitro fertilization parameters (Antral follicle count, oocyte, and embryo count), biochemical and spontaneous pregnancy and livebirth were measured.

RESULTS

38 eligible studies were identified reporting on 2256 women. The level of AMH rised, the level of FSH decreased significantly after the PRP treatment. AMH 1 month MD 0.20 (n = 856, p > 0.001, 95% CI: [0.12;0.28]), 2 months MD 0.26 (n = 910, p = 0.013, 95% CI: [0.07;0.44]), 3 months MD 0.36 (n = 881, p = 0.002,95% CI: [0.20;0.52]). FSH 1 month MD -10.20 (n = 796, p > 0.039, 95% CI: [-19.80;-0.61]), 2 months MD -7.02 (n = 910, p = 0.017, 95% CI: [-12.48; -1.57]), 3 months MD -8.87 (n = 809, p = 0.010, 95% CI: [-14.19; -3.55]). The antral follicle count elevated significantly MD 1.60 (n = 1418, p =  < 0.001, 95% CI: [0.92; 2.27]). Significant improvement was observed in the number of retrieved oocytes MD 0.81 (n = 802, p = 0.002, 95% CI: [0.36; 1.26]), and embryos created MD 0.91 (n = 616, p = 0.001, 95% CI: [0.45;1.36]). The incidence of spontaneous pregnancy following PRP treatment showed a rate with a proportion of 0.07 (n = 1370, 95% CI: 0.04-0.12), the rate of biochemical pregnancy was 0.18 (n = 1800, 95% CI: 0.15-0.22), livebirth was 0.11 (n = 1482, 95% CI: 0.07-0.15).

CONCLUSIONS

Our meta-analysis showed that based on protocolized analysis of the widest scientific literature search to date, containing predominantly observational studies, PRP treatment resulted in a statistically significant improvement in the main fertility parameters of diminished ovarian reserve women. Further multicenter, randomized trials, with large patient numbers and a longer follow-up period are needed to certify our results and develop the most effective treatment protocol.

摘要

简介

卵巢储备功能减退导致的不孕发生率已成为全球重大问题。PRP 治疗卵巢的有益效果已被描述,但尚未证明其有效性的高级别证据。

材料与方法

在五个数据库中进行了系统检索,截至 2024 年 3 月 12 日。符合纳入标准的研究为比较卵巢储备功能减退女性 PRP 治疗与自身对照的随机和非随机研究。测量的激素水平(抗苗勒管激素(AMH)、卵泡刺激素(FSH)、促黄体生成素(LH)、雌二醇(E2)、体外受精参数(窦卵泡计数、卵子和胚胎计数)、生化和自然妊娠及活产。

结果

确定了 38 项符合条件的研究,共报告了 2256 名女性。PRP 治疗后 AMH 水平升高,FSH 水平显著降低。PRP 治疗 1 个月后 AMH MD 0.20(n=856,p>0.001,95%CI:[0.12;0.28]),2 个月后 MD 0.26(n=910,p=0.013,95%CI:[0.07;0.44]),3 个月后 MD 0.36(n=881,p=0.002,95%CI:[0.20;0.52])。FSH 治疗 1 个月后 MD-10.20(n=796,p>0.039,95%CI:[-19.80;-0.61]),2 个月后 MD-7.02(n=910,p=0.017,95%CI:[-12.48;-1.57]),3 个月后 MD-8.87(n=809,p=0.010,95%CI:[-14.19;-3.55])。窦卵泡计数显著升高 MD 1.60(n=1418,p= <0.001,95%CI:[0.92;2.27])。获得的卵子数量明显增加 MD 0.81(n=802,p=0.002,95%CI:[0.36;1.26]),胚胎数量增加 MD 0.91(n=616,p=0.001,95%CI:[0.45;1.36])。PRP 治疗后的自然妊娠发生率为 0.07(n=1370,95%CI:0.04-0.12),生化妊娠发生率为 0.18(n=1800,95%CI:0.15-0.22),活产率为 0.11(n=1482,95%CI:0.07-0.15)。

结论

我们的荟萃分析表明,基于迄今为止最广泛的科学文献检索的方案分析,主要包含观察性研究,PRP 治疗可显著改善卵巢储备功能减退女性的主要生育参数。需要进行更多的多中心、随机试验,纳入大量患者并进行更长时间的随访,以验证我们的结果并制定最有效的治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7f/11100055/fc9b13b34be4/13048_2024_1423_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7f/11100055/bb04ce4539bc/13048_2024_1423_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7f/11100055/a66d868c7131/13048_2024_1423_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7f/11100055/96e5e4b54477/13048_2024_1423_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7f/11100055/30e1677ec6d2/13048_2024_1423_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7f/11100055/402480e66bb5/13048_2024_1423_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7f/11100055/fc9b13b34be4/13048_2024_1423_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7f/11100055/bb04ce4539bc/13048_2024_1423_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7f/11100055/a66d868c7131/13048_2024_1423_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7f/11100055/96e5e4b54477/13048_2024_1423_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7f/11100055/30e1677ec6d2/13048_2024_1423_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7f/11100055/402480e66bb5/13048_2024_1423_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac7f/11100055/fc9b13b34be4/13048_2024_1423_Fig6_HTML.jpg

相似文献

1
Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis.富血小板血浆(PRP)治疗卵巢可显著改善卵巢储备功能降低患者的生育参数和生殖结局:系统评价和荟萃分析。
J Ovarian Res. 2024 May 17;17(1):104. doi: 10.1186/s13048-024-01423-2.
2
Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis.自体富血小板血浆卵巢内注射治疗卵巢低反应患者的疗效:系统评价和荟萃分析。
Arch Gynecol Obstet. 2024 Jun;309(6):2323-2338. doi: 10.1007/s00404-024-07442-0. Epub 2024 Apr 8.
3
The effect of ovarian injection of autologous platelet rich plasma in patients with poor ovarian responder: a systematic review and meta-analysis.卵巢自体富血小板血浆注射对卵巢低反应患者的影响:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2023 Dec 12;14:1292168. doi: 10.3389/fendo.2023.1292168. eCollection 2023.
4
The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study.自身富含血小板血浆(PRP)与不干预在卵巢储备功能低下的接受生育治疗的女性中的应用:一项非随机干预研究。
J Assist Reprod Genet. 2020 Apr;37(4):855-863. doi: 10.1007/s10815-020-01710-z. Epub 2020 Feb 7.
5
Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial.在卵巢刺激过程中联合使用来曲唑对卵巢储备功能正常女性的卵母细胞产量、胚胎发育及活产率的影响:RIOT试验的次要结果
Hum Reprod. 2023 Nov 2;38(11):2154-2165. doi: 10.1093/humrep/dead182.
6
Intra-ovarian infusion of autologous platelet-rich plasma in women with poor ovarian reserve: A before and after study.卵巢内自体富含血小板血浆输注治疗卵巢储备功能不良患者的前后研究。
Eur J Obstet Gynecol Reprod Biol. 2023 Jan;280:60-63. doi: 10.1016/j.ejogrb.2022.11.001. Epub 2022 Nov 4.
7
AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.抗缪勒管激素在预测高龄行体外受精/卵胞浆内单精子注射周期妇女卵母细胞质量方面没有作用。
Sci Rep. 2020 Nov 12;10(1):19750. doi: 10.1038/s41598-020-76543-y.
8
Diminished ovarian reserve in recurrent pregnancy loss: a systematic review and meta-analysis.反复妊娠丢失中卵巢储备功能降低:一项系统评价和荟萃分析。
Fertil Steril. 2020 Apr;113(4):818-827.e3. doi: 10.1016/j.fertnstert.2019.11.014. Epub 2020 Mar 4.
9
Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency.自体富血小板血浆卵巢内注射对卵巢反应不良和原发性卵巢功能不全患者卵巢功能恢复的影响。
Reprod Sci. 2021 Jul;28(7):2050-2059. doi: 10.1007/s43032-021-00483-9. Epub 2021 Mar 8.
10
Relationship Between Anti-Müllerian Hormone and Fertilization-Embryo Transfer in Clinical Pregnancy.抗苗勒管激素与临床妊娠中受精-胚胎移植的关系。
Front Endocrinol (Lausanne). 2020 Dec 4;11:595448. doi: 10.3389/fendo.2020.595448. eCollection 2020.

引用本文的文献

1
Platelet-rich plasma (PRP) and the future of male fertility: a path forward for personalized and regenerative therapies.富血小板血浆(PRP)与男性生育的未来:个性化和再生疗法的前进道路。
Stem Cell Res Ther. 2025 Sep 2;16(1):486. doi: 10.1186/s13287-025-04602-0.
2
Ovarian Function Restoration Using Autologous Platelet-Rich Plasma.使用自体富血小板血浆恢复卵巢功能。
Reprod Med Biol. 2025 Jul 16;24(1):e12666. doi: 10.1002/rmb2.12666. eCollection 2025 Jan-Dec.
3
Comparative analysis of the use of autologous exosomes and platelet-derived growth factors in women with premature ovarian insufficiency and infertility: A prospective, randomized, observational, analytical study.

本文引用的文献

1
Enhancement of Ovarian Reserve and Oocyte Quality After Platelet-Rich Plasma Instillation in a Woman With Diminished Anti-Müllerian Hormone.抗苗勒管激素水平降低的女性经富血小板血浆灌注后卵巢储备和卵母细胞质量的改善
Cureus. 2024 Feb 2;16(2):e53474. doi: 10.7759/cureus.53474. eCollection 2024 Feb.
2
Intraovarian platelet-rich plasma injection and IVF outcomes in patients with poor ovarian response: a double-blind randomized controlled trial.卵巢内富含血小板血浆注射联合 IVF 治疗卵巢反应不良患者的结局:一项双盲随机对照试验。
Hum Reprod. 2024 Apr 3;39(4):760-769. doi: 10.1093/humrep/deae038.
3
The value of intraovarian autologous platelet rich plasma in women with poor ovarian reserve or ovarian insufficiency: a systematic review and meta-analysis.
自体外泌体与血小板衍生生长因子在卵巢早衰和不孕症女性中的应用比较分析:一项前瞻性、随机、观察性、分析性研究。
Regen Ther. 2025 Jun 30;30:309-320. doi: 10.1016/j.reth.2025.06.007. eCollection 2025 Dec.
4
Evaluating the Effectiveness of Platelet Rich Plasma Therapy in Enhancing Endometrial Receptivity for Women with Infertility: A Narrative Review.评估富血小板血浆疗法对提高不孕症女性子宫内膜容受性的有效性:一项叙述性综述。
J Pharm Bioallied Sci. 2025 May;17(Suppl 1):S137-S140. doi: 10.4103/jpbs.jpbs_1876_24. Epub 2025 Apr 21.
5
Intraovarian platelet-rich plasma (PRP) infusion appeared to benefit low prognosis IVF patients; however, when compared to controls, no significant benefit could be confirmed.卵巢内注射富血小板血浆(PRP)似乎对体外受精(IVF)预后较差的患者有益;然而,与对照组相比,未证实有显著益处。
J Assist Reprod Genet. 2025 Jun 2. doi: 10.1007/s10815-025-03530-5.
6
Platelet-Rich Plasma (PRP) in Reproductive Medicine: A Critical Review of PRP Therapy in Low-Reserve and Premature Ovarian Insufficiency.富血小板血浆(PRP)在生殖医学中的应用:对低储备和卵巢早衰中PRP治疗的批判性综述
Biomedicines. 2025 May 21;13(5):1257. doi: 10.3390/biomedicines13051257.
7
Platelet rich plasma for assisted reproduction: an overview of systematic reviews.富血小板血浆在辅助生殖中的应用:系统评价综述
Blood Transfus. 2025 Jul-Aug;23(4):322-337. doi: 10.2450/BloodTransfus.937. Epub 2025 Apr 15.
8
Platelet-rich plasma activation: are there differential effects in reproductive medicine?富血小板血浆激活:在生殖医学中有不同的影响吗?
J Ovarian Res. 2025 Apr 24;18(1):84. doi: 10.1186/s13048-025-01667-6.
9
Intra-ovarian injection of autologous menstrual blood-derived-mesenchymal stromal cells: a safe and promising method to improve pregnancy rate in poor ovarian responders.卵巢内注射自体月经血来源的间充质基质细胞:一种提高卵巢反应不良患者妊娠率的安全且有前景的方法。
Stem Cell Res Ther. 2025 Apr 12;16(1):171. doi: 10.1186/s13287-025-04278-6.
10
Platelet-Rich Plasma and Electrochemical Biosensors: A Novel Approach to Ovarian Function Evaluation and Diagnostics.富血小板血浆与电化学生物传感器:一种评估和诊断卵巢功能的新方法。
Int J Mol Sci. 2025 Mar 5;26(5):2317. doi: 10.3390/ijms26052317.
卵巢内自体富血小板血浆对卵巢储备功能不良或卵巢功能不全女性的价值:一项系统评价和荟萃分析。
BMC Pregnancy Childbirth. 2024 Jan 27;24(1):85. doi: 10.1186/s12884-024-06251-2.
4
The efficacy of platelet rich plasma on women with poor ovarian response: a systematic review and meta-analysis.富血小板血浆治疗卵巢低反应患者的疗效:系统评价和荟萃分析。
Platelets. 2024 Dec;35(1):2292612. doi: 10.1080/09537104.2023.2292612. Epub 2024 Jan 12.
5
Treatment of ovarian damage induced by chemotherapeutic drugs in female rats with G-CSF and platelet-rich plasma(PRP): an immunohistochemical study correlation with novel marker INSL-3.用粒细胞集落刺激因子(G-CSF)和富血小板血浆(PRP)治疗雌性大鼠化疗药物所致卵巢损伤:一项与新型标志物胰岛素样肽-3(INSL-3)相关的免疫组织化学研究
Gynecol Endocrinol. 2024 Dec;40(1):2301551. doi: 10.1080/09513590.2023.2301551. Epub 2024 Jan 9.
6
The effect of ovarian injection of autologous platelet rich plasma in patients with poor ovarian responder: a systematic review and meta-analysis.卵巢自体富血小板血浆注射对卵巢低反应患者的影响:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2023 Dec 12;14:1292168. doi: 10.3389/fendo.2023.1292168. eCollection 2023.
7
Does Platelet-Rich Plasma Treatment Increase In Vitro Fertilization (IVF) Success in the Infertile Population?富含血小板血浆治疗能否提高不育人群体外受精(IVF)的成功率?
Cureus. 2023 Oct 17;15(10):e47239. doi: 10.7759/cureus.47239. eCollection 2023 Oct.
8
Beneficial effects of intraovarian injection of platelet-rich plasma in women with poor ovarian response.卵巢内注射富血小板血浆对卵巢反应不良女性的有益作用。
Clin Exp Reprod Med. 2023 Dec;50(4):285-291. doi: 10.5653/cerm.2023.06086. Epub 2023 Oct 24.
9
Effect of intra-ovarian platelet rich plasma in women with poor ovarian response.卵巢内注射富血小板血浆对卵巢反应不良女性的影响。
Caspian J Intern Med. 2023 Summer;14(3):485-489. doi: 10.22088/cjim.14.3.485.
10
Clinical Benefit of Autologous Platelet-Rich Plasma Infusion in Ovarian Function Rejuvenation: Evidence from a Before-After Prospective Pilot Study.自体富血小板血浆输注对卵巢功能恢复的临床益处:一项前后对照前瞻性初步研究的证据
Medicines (Basel). 2023 Feb 27;10(3):19. doi: 10.3390/medicines10030019.